THEMISMED Stock Overview
Manufactures and sells pharmaceutical products in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
No risks detected for THEMISMED from our risk checks.
Themis Medicare Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹295.00 |
| 52 Week High | ₹317.00 |
| 52 Week Low | ₹156.05 |
| Beta | 0.58 |
| 11 Month Change | 11.05% |
| 3 Month Change | 14.61% |
| 1 Year Change | 90.63% |
| 33 Year Change | 223.31% |
| 5 Year Change | 1,053.24% |
| Change since IPO | 2,199.30% |
Recent News & Updates
Recent updates
What Themis Medicare Limited's (NSE:THEMISMED) 42% Share Price Gain Is Not Telling You
Dec 27
Themis Medicare (NSE:THEMISMED) Takes On Some Risk With Its Use Of Debt
Dec 01Themis Medicare (NSE:THEMISMED) Has Affirmed Its Dividend Of ₹5.00
Aug 18Themis Medicare's (NSE:THEMISMED) Dividend Will Be ₹5.00
Aug 04Themis Medicare's (NSE:THEMISMED) Dividend Will Be ₹5.00
Jul 18We Think Themis Medicare (NSE:THEMISMED) Is Taking Some Risk With Its Debt
Jul 08Themis Medicare (NSE:THEMISMED) Is Due To Pay A Dividend Of ₹5.00
May 18Themis Medicare (NSE:THEMISMED) Seems To Use Debt Quite Sensibly
Dec 21Themis Medicare (NSE:THEMISMED) Has Announced That It Will Be Increasing Its Dividend To ₹5.00
Aug 28Themis Medicare (NSE:THEMISMED) Is Increasing Its Dividend To ₹5.00
Aug 08Themis Medicare's (NSE:THEMISMED) Upcoming Dividend Will Be Larger Than Last Year's
Jul 21Themis Medicare's (NSE:THEMISMED) Upcoming Dividend Will Be Larger Than Last Year's
May 27Is Now The Time To Put Themis Medicare (NSE:THEMISMED) On Your Watchlist?
May 12Calculating The Fair Value Of Themis Medicare Limited (NSE:THEMISMED)
Nov 09Is Now The Time To Put Themis Medicare (NSE:THEMISMED) On Your Watchlist?
Oct 26Increases to Themis Medicare Limited's (NSE:THEMISMED) CEO Compensation Might Cool off for now
Sep 11Themis Medicare (NSE:THEMISMED) Is Increasing Its Dividend To ₹4.30
Aug 16Do Themis Medicare's (NSE:THEMISMED) Earnings Warrant Your Attention?
Jul 09Shareholder Returns
| THEMISMED | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 3.2% | 0.5% | 0.5% |
| 1Y | 90.6% | 42.5% | 27.5% |
Return vs Industry: THEMISMED exceeded the Indian Pharmaceuticals industry which returned 42.5% over the past year.
Return vs Market: THEMISMED exceeded the Indian Market which returned 27.5% over the past year.
Price Volatility
| THEMISMED volatility | |
|---|---|
| THEMISMED Average Weekly Movement | 7.4% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: THEMISMED has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: THEMISMED's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1952 | 1,509 | Sachin Patel | www.themismedicare.com |
Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. The company offers active pharmaceutical ingredients (APIs) and formulations for use in various therapeutic areas, including anti-tuberculosis, anti-malarials, cardiology, pain management, anti-infectives, haematinics, health and nutrition, anaesthesia, gynecology, and orthopedics. It also offers anti-inflammatory drugs and other drugs.
Themis Medicare Limited Fundamentals Summary
| THEMISMED fundamental statistics | |
|---|---|
| Market cap | ₹27.16b |
| Earnings (TTM) | ₹529.90m |
| Revenue (TTM) | ₹4.20b |
51.3x
P/E Ratio6.5x
P/S RatioIs THEMISMED overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| THEMISMED income statement (TTM) | |
|---|---|
| Revenue | ₹4.20b |
| Cost of Revenue | ₹1.51b |
| Gross Profit | ₹2.70b |
| Other Expenses | ₹2.17b |
| Earnings | ₹529.90m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 14, 2025
| Earnings per share (EPS) | 5.76 |
| Gross Margin | 64.13% |
| Net Profit Margin | 12.61% |
| Debt/Equity Ratio | 19.8% |
How did THEMISMED perform over the long term?
See historical performance and comparison